Pubblicazioni

Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study

2020 - BLOOD CANCER JOURNAL

Locatelli, F.; Zugmaier, G.; Mergen, N.; Bader, P.; Jeha, S.; Schlegel, P. -G.; Bourquin, J. -P.; Handgretinger, R.; Brethon, B.; Rossig, C.; Chen-Santel, C.

Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study

2020 - BLOOD CANCER JOURNAL

Locatelli, F.; Zugmaier, G.; Mergen, N.; Bader, P.; Jeha, S.; Schlegel, P. -G.; Bourquin, J. -P.; Handgretinger, R.; Brethon, B.; Rossig, C.; Chen-Santel, C.

Repurposing anthelmintic agents to eradicate resistant leukemia

2020 - BLOOD CANCER JOURNAL

Mezzatesta, C.; Abduli, L.; Guinot, A.; Eckert, C.; Schewe, D.; Zaliova, M.; Vinti, L.; Marovca, B.; Tsai, Y. -C.; Jenni, S.; Aguade-Gorgorio, J.; von Stackelberg, A.; Schrappe, M.; Locatelli, F.; Stanulla, M.; Cario, G.; Bourquin, J. -P.; Bornhauser, B. C.

Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia

2018 - BLOOD CANCER JOURNAL

Gore, L.; Locatelli, F.; Zugmaier, G.; Handgretinger, R.; O'Brien, M. M.; Bader, P.; Bhojwani, D.; Schlegel, P. -G.; Tuglus, C. A.; von Stackelberg, A.